Corcept Therapeutics (NASDAQ:CORT – Get Free Report) had its price target increased by analysts at Piper Sandler from $67.00 ...

Lemonade (NYSE:LMND – Free Report) had its price objective reduced by Piper Sandler from $44.00 to $34.00 in a report ...

Fintel reports that on February 28, 2025, Piper Sandler downgraded their outlook for Teleflex (NYSE:TFX) from Overweight to ...

Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at ...

Piper Sandler lowered the firm’s price target on Dyne Therapeutics (DYN) to $48 from $53 following ATM dilution, while keeping an Overweight ...

Piper Sandler analyst Stephen Scouten maintained a Hold rating on Seacoast Banking Of Florida (SBCF – Research Report) today and set a price ...

Looking at more recent history, Kantrowitz noted that every correction from the late 1990s until 2018 "were all growth-driven market corrections." The two since 2022 have been rates-driven selloffs, ...

The only negative coming out of Nvidia's earnings? Expectations for a 71% adjusted gross margin this quarter as the company continues ahead with its Blackwell ramp, according to Piper Sandler analyst ...

Nvidia (NASDAQ:NVDA) is once again at the center of Wall Street's attention as analysts set the stage for another strong ...

Nvidia (NASDAQ:NVDA) is in the spotlight ahead of its Q4 earnings, with Evercore ISI and Piper Sandler sticking to their ...

Nvidia (NVDA) was in focus on Tuesday as investment firms Evercore ISI and Piper Sandler issued positive notes on the ...